Related references
Note: Only part of the references are listed.Periodically repeated rituximab administrations in children with refractory nephrotic syndrome: 2-year multicenter observational study
Toshiyuki Takahashi et al.
PEDIATRIC NEPHROLOGY (2019)
Effect of different rituximab regimens on B cell depletion and time to relapse in children with steroid-dependent nephrotic syndrome
Julien Hogan et al.
PEDIATRIC NEPHROLOGY (2019)
Successful management of post-transplant focal segmental glomerulosclerosis with therapeutic plasma exchange and rituximab
Konstantinos Koutroutsos et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2019)
Multicenter analysis of the efficacy and safety of a non-standard immunosuppressive therapy with rituximab in children with steroid-resistant nephrotic syndrome
Jacek Zachwieja et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2019)
Idiopathic nephrotic syndrome and rituximab: may we predict circulating B lymphocytes recovery?
Jean Daniel Delbet et al.
PEDIATRIC NEPHROLOGY (2019)
Low-dose rituximab is no less effective for nephrotic syndrome measured by 12-month outcome
Andrew P. Maxted et al.
PEDIATRIC NEPHROLOGY (2019)
How to improve response to rituximab treatment in children with steroid-dependent nephrotic syndrome: answer to Drs. Fujinaga and Nishino
Julien Hogan et al.
PEDIATRIC NEPHROLOGY (2019)
Long-term outcomes after early treatment with rituximab for Japanese children with cyclosporine- and steroid-resistant nephrotic syndrome
Shuichiro Fujinaga et al.
PEDIATRIC NEPHROLOGY (2019)
Crohn's disease following rituximab treatment in a patient with refractory nephrotic syndrome
Keishi Morita et al.
CEN CASE REPORTS (2019)
Cost analysis on the use of rituximab and calcineurin inhibitors in children and adolescents with steroid-dependent nephrotic syndrome
Franca Iorember et al.
PEDIATRIC NEPHROLOGY (2018)
Adverse events linked with the use of chimeric and humanized anti-CD20 antibodies in children with idiopathic nephrotic syndrome
Alice Bonanni et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
NEPHRUTIX: A randomized, double-blind, placebo vs Rituximab-controlled trial assessing T-cell subset changes in Minimal Change Nephrotic Syndrome
Ahmed Boumediene et al.
JOURNAL OF AUTOIMMUNITY (2018)
FP773EFFICACY OF TWO VERSUS FOUR DOSES OF RITUXIMAB FOR CHILDHOOD NEPHROTIC SYNDROME
Deirdre Hahn et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Infusion reactions associated with rituximab treatment for childhood-onset complicated nephrotic syndrome
Koichi Kamei et al.
PEDIATRIC NEPHROLOGY (2018)
Efficacy of Rituximab vs Tacrolimus in Pediatric Corticosteroid-Dependent Nephrotic Syndrome A Randomized Clinical Trial
Biswanath Basu et al.
JAMA PEDIATRICS (2018)
Comparison of the response of frequently relapsing steroid-dependent minimal change nephrotic syndrome to rituximab therapy between childhood-onset and adult-onset disease
Yuko Iwabuchi et al.
MEDICINE (2018)
Efficacy and safety of rituximab in childhood-onset, difficult-to-treat nephrotic syndrome A multicenter open-label trial in Korea
Yo Han Ahn et al.
MEDICINE (2018)
Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab
Nada Alachkar et al.
BMC NEPHROLOGY (2018)
Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07)
Tomoko Horinouchi et al.
BMC NEPHROLOGY (2018)
Serum sickness with refractory nephrotic syndrome following treatment with rituximab
Ryo Maeda et al.
CEN CASE REPORTS (2018)
Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
Frank B. Cortazar et al.
KIDNEY INTERNATIONAL REPORTS (2018)
Relapse of nephrotic syndrome during post-rituximab peripheral blood B-lymphocyte depletion
Mai Sato et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2018)
Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment
Shuichiro Fujinaga et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2017)
Rituximab protects podocytes and exerts anti-proteinuric effects in rat adriamycin-induced nephropathy independent of B-lymphocytes
Yuichi Takahashi et al.
NEPHROLOGY (2017)
Rituximab in children with steroid-dependent nephrotic syndrome: experience of a tertiary center and review of the literature
Ilse Van Horebeek et al.
ACTA CLINICA BELGICA (2017)
Detection and quantification of rituximab in the human urine
Roland Jacobs et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2017)
Long-term outcome of childhood-onset complicated nephrotic syndrome after a multicenter, double-blind, randomized, placebo-controlled trial of rituximab
Koichi Kamei et al.
PEDIATRIC NEPHROLOGY (2017)
Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: study protocol
Pietro Ravani et al.
BMJ OPEN (2017)
Cost-Effectiveness of Administering Rituximab for Steroid-Dependent Nephrotic Syndrome and Frequently Relapsing Nephrotic Syndrome: A Preliminary Study in Japan
Tomoyuki Takura et al.
SCIENTIFIC REPORTS (2017)
Infectious complications of a rituximab-based immunosuppressive regimen in patients with glomerular disease
Claire Trivin et al.
CLINICAL KIDNEY JOURNAL (2017)
Acute demyelinating neuropathy associated with rituximab treatment in a patient with relapsing nephrotic syndrome
Giuliana Galassi et al.
CEN CASE REPORTS (2017)
Effectiveness of rituximab in nephrotic syndrome treatment
Katarzyna Popko et al.
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Long-term repeated rituximab treatment for childhood steroid-dependent nephrotic syndrome
Ji Hyun Kim et al.
KIDNEY RESEARCH AND CLINICAL PRACTICE (2017)
B cell repopulation kinetics after rituximab treatment in ANCA-associated vasculitides compared to rheumatoid arthritis, and connective tissue diseases: a longitudinal observational study on 120 patients
Jens Thiel et al.
ARTHRITIS RESEARCH & THERAPY (2017)
B Cell Reconstitution after Rituximab Treatment in Idiopathic Nephrotic Syndrome
Manuela Colucci et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome
Hazel Webb et al.
PEDIATRIC NEPHROLOGY (2016)
New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature
D. Roccatello et al.
AUTOIMMUNITY REVIEWS (2016)
Late-onset adverse events after a single dose of rituximab in children with complicated steroid-dependent nephrotic syndrome
Shuichiro Fujinaga et al.
CLINICAL NEPHROLOGY (2016)
Rituximab is not a magic drug in post-transplant recurrence of nephrotic syndrome
Ryszard Grenda et al.
EUROPEAN JOURNAL OF PEDIATRICS (2016)
Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO)
Adi Vaknin-Dembinsky et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Efficacy of rituximab therapy against intractable steroid-resistant nephrotic syndrome
Taku Nakagawa et al.
PEDIATRICS INTERNATIONAL (2016)
Rituximab and low-dose cyclosporine combination therapy for steroid-resistant focal segmental glomerulosclerosis
Kazuhide Suyama et al.
PEDIATRICS INTERNATIONAL (2016)
The role of plasma exchange in treating post-transplant focal segmental glomerulosclerosis: A systematic review and meta-analysis of 77 case-reports and case-series
Abdullah Kashgary et al.
BMC NEPHROLOGY (2016)
Ethnic Differences in Childhood Nephrotic Syndrome
Rahul Chanchlani et al.
FRONTIERS IN PEDIATRICS (2016)
Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis
Jeremie Sellam et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Single dose of rituximab in children with steroid-dependent minimal change nephrotic syndrome
Xiao-Ling Niu et al.
BIOMEDICAL REPORTS (2016)
Usefulness of monitoring of B cell depletion in rituximab-treated rheumatoid arthritis patients in order to predict clinical relapse: a prospective observational study
A. -P. Trouvin et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
Rituximab-associated hypogammaglobulinemia: Incidence, predictors and outcomes in patients with multi-system autoimmune disease
Darren M. Roberts et al.
JOURNAL OF AUTOIMMUNITY (2015)
Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial
Pietro Ravani et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Pharmacokinetics of rituximab in a pediatric patient with therapy-resistant nephrotic syndrome
Clare E. Counsilman et al.
PEDIATRIC NEPHROLOGY (2015)
Positive role of rituximab in switching from cyclosporine to mycophenolate mofetil for children with high-dose steroid-dependent nephrotic syndrome
Shuichiro Fujinaga et al.
PEDIATRIC NEPHROLOGY (2015)
Fatal rituximab-associated lung injury syndrome in a patient treated with rituximab for recurrence of post-transplant nephrotic syndrome
Ryszard Grenda et al.
PEDIATRIC TRANSPLANTATION (2015)
Mycophenolate Mofetil Following Rituximab in Children With Steroid-Resistant Nephrotic Syndrome
Biswanath Basu et al.
PEDIATRICS (2015)
Circulating CD4+T-cell number decreases in rheumatoid patients with clinical response to rituximab
Silvia Piantoni et al.
RHEUMATOLOGY INTERNATIONAL (2015)
Trends in the histopathology of childhood nephrotic syndrome in Ibadan Nigeria: preponderance of idiopathic focal segmental glomerulosclerosis
Adanze O. Asinobi et al.
BMC NEPHROLOGY (2015)
Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome
Aditi Sinha et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Rituximab in Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome
Piero Ruggenenti et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial
Kazumoto Iijima et al.
LANCET (2014)
Prolonged B Cell Depletion With Rituximab is Effective in Treating Refractory Pulmonary Granulomatous Inflammation in Granulomatosis With Polyangiitis (GPA)
Scott R. Henderson et al.
MEDICINE (2014)
Re-treatment with high-dose prednisolone after rituximab infusion for childhood-onset steroid-resistant nephrotic syndrome
Shuichiro Fujinaga et al.
PEDIATRIC NEPHROLOGY (2014)
Impact of rituximab on height and weight in children with refractory steroid-dependent nephrotic syndrome
Mai Sato et al.
PEDIATRIC NEPHROLOGY (2014)
Development of antirituximab antibodies in children with nephrotic syndrome
Yo Han Ahn et al.
PEDIATRIC NEPHROLOGY (2014)
Rituximab treatment combined with methylprednisolone pulse therapy and immunosuppressants for childhood steroid-resistant nephrotic syndrome
Koichi Kamei et al.
PEDIATRIC NEPHROLOGY (2014)
Success with plasmapheresis treatment for recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients
Caroline Straatmann et al.
PEDIATRIC TRANSPLANTATION (2014)
Efficacy of rituximab therapy in children with refractory nephrotic syndrome: a prospective observational study in Shanghai
Li Sun et al.
WORLD JOURNAL OF PEDIATRICS (2014)
Direct and indirect rituximab-induced T cell depletion: comment on the article by Melet et al
Paul Eggleton et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Rituximab-Induced T Cell Depletion in Patients With Rheumatoid Arthritis Association With Clinical Response
J. Melet et al.
ARTHRITIS AND RHEUMATISM (2013)
Cyclosporine versus mycophenolate mofetil for maintenance of remission of steroid-dependent nephrotic syndrome after a single infusion of rituximab
Shuichiro Fujinaga et al.
EUROPEAN JOURNAL OF PEDIATRICS (2013)
Persistent Hypogammaglobulinemia After Rituximab Treatment
Yelena Kopyltsova et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome
Pietro Ravani et al.
KIDNEY INTERNATIONAL (2013)
Rituximab in post-transplant pediatric recurrent focal segmental glomerulosclerosis
Juhi Kumar et al.
PEDIATRIC NEPHROLOGY (2013)
Atypical Pneumocystis jiroveci pneumonia with multiple nodular granulomas after rituximab for refractory nephrotic syndrome
Mai Sato et al.
PEDIATRIC NEPHROLOGY (2013)
Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome
Shuichi Ito et al.
PEDIATRIC NEPHROLOGY (2013)
Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome
Stephanie Tellier et al.
PEDIATRIC NEPHROLOGY (2013)
Difficulties in diagnosing severe Pneumocystis jiroveci pneumonia after rituximab therapy for steroid-dependent nephrotic syndrome
Piotr Czarniak et al.
PEDIATRIC NEPHROLOGY (2013)
Fulminant viral myocarditis after rituximab therapy in pediatric nephrotic syndrome
Anne-Laure Sellier-Leclerc et al.
PEDIATRIC NEPHROLOGY (2013)
Circulating suPAR in Two Cohorts of Primary FSGS
Changli Wei et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Rituximab in Children with Resistant Idiopathic Nephrotic Syndrome
Alberto Magnasco et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood-follow-up after CD19 recovery
Anne-Laure Sellier-Leclerc et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome
Markus J. Kemper et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Rituximab treatment for recurrence of nephrotic syndrome in a pediatric patient after renal transplantation for congenital nephrotic syndrome of Finnish type
Abanti Chaudhuri et al.
PEDIATRIC TRANSPLANTATION (2012)
Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective
Pashtoon M. Kasi et al.
CRITICAL CARE (2012)
B Cell Activation Biomarkers as Predictive Factors for the Response to Rituximab in Rheumatoid Arthritis
Jeremie Sellam et al.
ARTHRITIS AND RHEUMATISM (2011)
B Cell Biomarkers of Rituximab Responses in Systemic Lupus Erythematosus
Edward M. Vital et al.
ARTHRITIS AND RHEUMATISM (2011)
Short-Term Effects of Rituximab in Children with Steroid- and Calcineurin-Dependent Nephrotic Syndrome: A Randomized Controlled Trial
Pietro Ravani et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
Changli Wei et al.
NATURE MEDICINE (2011)
Maintenance therapy with mycophenolate mofetil after rituximab in pediatric patients with steroid-dependent nephrotic syndrome
Shuichi Ito et al.
PEDIATRIC NEPHROLOGY (2011)
Rituximab for refractory cases of childhood nephrotic syndrome
Jameela A. Kari et al.
PEDIATRIC NEPHROLOGY (2011)
Should we consider MMF therapy after rituximab for nephrotic syndrome?
Guido Filler et al.
PEDIATRIC NEPHROLOGY (2011)
Long-term effect of rituximab in maintaining remission of recurrent and plasmapheresis-dependent nephrotic syndrome post-renal transplantation - Case report
Ryszard Grenda et al.
PEDIATRIC TRANSPLANTATION (2011)
Rituximab Targets Podocytes in Recurrent Focal Segmental Glomerulosclerosis
Alessia Fornoni et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Increased IL-2, IL-4 and interferon-gamma (IFN-γ) in steroid-sensitive nephrotic syndrome
T. J. NEUHAUS et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome: Multicentric Report
Ashima Gulati et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Late-Onset Neutropenia After Rituximab Treatment Case Series and Comprehensive Review of the Literature
Ofir Wolach et al.
MEDICINE (2010)
Rituximab in refractory nephrotic syndrome
Agnieszka Prytula et al.
PEDIATRIC NEPHROLOGY (2010)
Rituximab efficiency in children with steroid-dependent nephrotic syndrome
Anne-Laure Sellier-Leclerc et al.
PEDIATRIC NEPHROLOGY (2010)
Severe Ulcerative Colitis After Rituximab Therapy
Daniela S. Ardelean et al.
PEDIATRICS (2010)
Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children
Koichi Kamei et al.
PEDIATRIC NEPHROLOGY (2009)
Rituximab for post-transplant recurrences of FSGS
Umut Selda Bayrakci et al.
PEDIATRIC TRANSPLANTATION (2009)
Remission of steroid-resistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab
Megha Suri et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2008)
Anti-CD20 (rituximab) treatment improves atopic eczema
Dagmar Simon et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases
Vincent Guigonis et al.
PEDIATRIC NEPHROLOGY (2008)
Rituximab for refractory focal segmental glomerulosclerosis
Makiko Nakayama et al.
PEDIATRIC NEPHROLOGY (2008)
Post-transplant focal segmental glomerulosclerosis refractory to plasmapheresis and rituximab therapy
Ali El-Firjani et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis
Edward Keystone et al.
ARTHRITIS AND RHEUMATISM (2007)
Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis after renal transplantation treated with plasmapheresis and immunoadsorption:: Case reports
F. Fencl et al.
TRANSPLANTATION PROCEEDINGS (2007)
Rituximab in patients with the steroid-resistant nephrotic syndrome
Arvind Bagga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats
Kin-Wai Lai et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis
P. P. Sfikakis et al.
CLINICAL IMMUNOLOGY (2007)
Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult: First case report and pathophysiological considerations
Helene Francois et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
Rituximab therapy for steroid-dependent minimal change nephrotic syndrome
Rodney D. Gilbert et al.
PEDIATRIC NEPHROLOGY (2006)
Effect of post-transplant double filtration plasmapheresis on recurrent focal and segmental glomerulosclerosis in renal transplant recipients
S Otsubo et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2004)
Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy
K Benz et al.
PEDIATRIC NEPHROLOGY (2004)
Up-regulation of interleukin-2 mRNA in children with idiopathic nephrotic syndrome
H Shimoyama et al.
PEDIATRIC NEPHROLOGY (2004)
Dominant T cells in idiopathic nephrotic syndrome of childhood
C Frank et al.
KIDNEY INTERNATIONAL (2000)
Share Paper
